Needham & Company Starts DENTSPLY SIRONA (XRAY) at Buy, 'Visible EPS Growth Despite A Challenging Macro'
Tweet Send to a Friend
Needham & Company analyst David Saxon initiates coverage on DENTSPLY SIRONA (NASDAQ: XRAY) with a Buy rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
